{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"32 patients were treated with plitidepsin as single agent;afterwards 19 of them were treated with plitidepsin+dexamethasone combination.Therefore 32+19=51 is the no. patients at risk for plitidepsin and 19 is no. of patients at risk for dexamethasone"},"pointOfContact":{"email":"cscorrado@pharmamar.com","organization":"PharmaMar USA Inc","phone":"1 212 201 6770","title":"Claudia Silvia Corrado M.D."}}